This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Stratos Genomics, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Greg Thiessen: Innovator in DNA Polymerase Technology
Introduction
Greg Thiessen is a notable inventor based in Seattle, WA, who has made significant contributions to the field of biotechnology. His work primarily focuses on the development of DNA polymerase variants that enhance single molecule sequencing applications. With a patent portfolio that includes innovative solutions, Thiessen has established himself as a key figure in the industry.
Latest Patents
Greg Thiessen holds a patent for DP04 polymerase variants. This patent describes recombinant DP04-type DNA polymerase variants with amino acid substitutions that confer modified properties upon the polymerase. These modifications improve the polymerase's ability to bind and incorporate bulky nucleotide analog substrates into daughter strands. The patent also includes compositions comprising these DP04 variants and nucleotide analogs, as well as nucleic acids encoding the polymerases with the aforementioned phenotypes. He has 1 patent to his name.
Career Highlights
Throughout his career, Greg Thiessen has worked with prominent companies in the biotechnology sector. He has been associated with Stratos Genomics, Inc. and Roche Diagnostics GmbH, where he contributed to various innovative projects. His expertise in polymerase technology has been instrumental in advancing the capabilities of DNA sequencing.
Collaborations
Greg Thiessen has collaborated with several professionals in the field, including Mark Stamatios Kokoris and Marc Prindle. These collaborations have further enriched his work and contributed to the development of cutting-edge technologies in DNA sequencing.
Conclusion
Greg Thiessen's contributions to the field of DNA polymerase technology highlight his innovative spirit and dedication to advancing biotechnology. His patent for DP04 polymerase variants showcases his ability to address complex challenges in single molecule sequencing applications. Through his work, Thiessen continues to influence the future of genetic research and sequencing technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile